A Real-world Study Evaluating the Usage of Camrelizumab in Chinese Patients With Advanced Esophageal Cancer

NCT04616040 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
1030
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Peking University